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Since few years, some concerns appeared regarding the presence of polybrominated biphenyl 
ethers (PBDEs) in our environment1. Those chemicals are used as flame retardant in virtually most 
of our surrounding man-made materials. Despite the great protection those chemicals offer, they 
also can act as precursors for polybrominated dibenzo-p-dioxins and furans (PBDD/Fs)2 that are 
suspected to express similar toxicities than their chlorinated homologs3. Additionally, depending 
of their route of incorporation in the synthetic materials, PBDEs can relatively easily leach out 
during their life-time, even if no fire is involved. They can therefore become available to humans 
that are exposed via food consumption and air particulates breathing. 
As in the case of dioxins and related compounds, PBDEs are characterized by high lipophilic 
properties and are willing to bio accumulate. Although increasing levels have been reported in 
human last years4, very limited toxicological data are available so far5. It is however believed that 
thyroid hormone disruption, neurodevelopmental effects and, in a certain extend, cancer, can be 
listed as potential toxicological endpoints6. Developing babies and infants therefore represent one 
of the most sensitive layer of the population regarding exposure to those chemicals. 
The present study was carried out in order to give an estimate of the current PBDE background 
levels in breast milk of a selected Belgian population. 
 
 
Materials and methods 
Samples: Breast milk samples (N=14) issued from primi and multiparae women between the ages 
of 26 and 38. They were collected between August 2000 and April 2001 in Belgium (most of them 
in the city of Liege, Wallonia) at different times of lactation. Volunteers were asked to fill out a 
personal questionnaire including parameters of interest. Decontaminated collection vials and 
breast-pump were used by volunteers for sampling and samples were stored less than one day at 
4°C before freezing at –20°C until analysis. Portions of 10 ml were used for this study. 
Extraction and Clean-up: Samples were pre-treated prior extraction. Milk fat globules 
membranes were disrupted by potassium oxalate (1mg/g milk) and acetonitrile (1:1). Water was 
added to the milk (1:1) in order to decrease the viscosity of the mixture. Around 30 ml of pre-
treated sample was then loaded on Isolute Flash C18 cartridges (International Sorbent Technology, 
Hengoed, UK). These cartridges consisted of polypropylene syringe-barrels of 70 ml filled with 10 
g of non-endcapped C18 bonded silica sorbent (average particle size 50 µm, 60 Å porosity). 
Cartridges were used on a Flashvac® extraction vacuum manifold (IST). C18 sorbent was solvated 
using 2 volumes of acetonitrile and 2 volumes of water at 20 ml/min prior to the addition of 
sample at a maximum flow-rate of 10 ml/min. SPE cartridge were washed with twice 10 ml of 
water and 2 ml of methanol were added (to make drying easier) prior to 1 hour of drying under 
reduced pressure. PBDEs and PCBs were eluted using 4 times 15 ml of hexane at a flow rate of 5 
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ml/min. Extracts were concentrated to 15 ml using a Turbovap II Concentration Workstation 
(Zymark, Hopkinton, MA, USA) prior to further clean-up. Automated multi-column clean-up was 
performed on the Power-Prep System (Fluid Management Systems, Waltham, MA, USA). Details 
concerning the system are available elsewhere7. The set of column consisted in multi-layer silica 
(acidic, neutral and basic) and basic alumina. The lipid content determinations were carried out 
gravimetrically on the side of the analysis using small volume of milk. 
Analysis: Analyses were performed by tandem in time mass spectrometry (GC/MS/MS) using a 
ThermoQuest Trace GC PolarisQ ion trap mass spectrometer (Austin, TX, USA) and a Agilent 
(Palo Alto, CA, USA) 6890 Series gas chromatograph, the latter equipped with a Rtx 5-MS (40m 
x 0.18 mm x 0.18 µm) capillary column (Restek, Evry, France). Electronic impact was used as 
ionisation mode, with an energy of 70 eV. Quantification was performed using internal standards 
(isotopic dilution). Details are available elsewhere8. As QC samples, aliquots of a breast milk 




Results and Discussion 
As expected, the predominant PBDE congeners in the investigated human breast milk were 
BDE-47 and BDE-153, with concentrations of 1.7 ng/g and 0.4 ng/g on a lipid weight basis, 
respectively (Figure 1). Both BDE-47 and BDE-153 contribute for more than 75% of the measured 
concentrations (6 congeners). 
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Fig. 1 :  BDE concentrations and relative contributions in investigated Belgian breast milks. 
 
The sum of the 6 BDE congeners is equal to 2.85 ng/g lipid weight. This is inside the range of 
recently reported values for Belgian adipose tissues9. A significant difference was however present 
between the two studies for BDE-153 concentration that was about 6-fold higher for the adipose 
tissue study. The ratio of BDE-47 over BDE-153 was 3.9 for the present study versus 0.6 for the 
adipose tissue study. Additional samples of adipose tissues and breast milk should be collected in 
the country in order to assess any potential regional differences in the congener distribution. 
Furthermore, differences between breast milk and adipose tissue congener distribution are 
sometimes observed and make inter-matrix comparison delicate. 
A rapid calculation yield to a PBDE (6 congeners) intake value of 7 ng/kg of body weight/day or 
4.4 µg total over the 3 first months of breast feeding (600 ml of milk/day, 7 kg baby, 3.5% 
fat).Based on a previous market basket study5 reporting dietary intake of 0.73 ng/kg of body 
weight/day (70kg adult, 5 congeners), infants would then receive about 10-fold higher intake than 
adults. 
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As illustrated in Figure 2, the concentrations of the 6 reported PBDE congeners are similar to 
the ones measured in various countries, excluding the U.S.A. and Canada for which levels are 
much higher. Unfortunately, no anterior data on PBDE levels in human breast milk are available in 
Belgium and no time trend can be extracted yet. Additional sample collection will allow to see if 


























Czech Republic, 2001 [17]
 
Fig. 2 :  Comparison (Log scale) of the Belgian data with some reported BDE concentrations in human 
breast milk (except Norway (serum), Japan (adipose tissue) and Czech Republic (adipose 
tissue)). 
 
Although a correlation was observed for PCDD/F and PCB levels with age and parity18, no 
significant correlations were recorded for PBDEs. Such a difference is most probably connected to 
higher variability in exposure routes. 
The concentrations of the major PCB congeners were 105±63 ng/g, 79±44 ng/g and, 90±52 ng/g 
for PCB-153, PCB-138 and, PCB-180 on a lipid weight basis, respectively. Although the congener 
distribution is very similar, those concentrations are about half of the concentrations measured in 
the adipose tissue study9. This is not surprising since the mean age of the subject was about 15 
years lower and that some multiparae mothers were included in the present study. The interesting 
aspect is that such a difference is not observed for PBDEs, as illustrated in Table 1. PCB and 
PBDE distributions in human are clearly not affected by the same parameters and respond to 
different influences. 
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Breast milk 2000-2001 Adipose tissue9 2000
mean age 30.4 years mean age 47.2 years
women only men and women
Concentration (ng/g lipid weight) Contibution (%) Concentration (ng/g lipid weight) Contibution (%)
B-153 105.11 38.4 221.1 46.6
B-138 78.9 28.8 105.1 22.1
B-180 89.73 32.8 148.3 31.3
E-47 1.69 68.4 1.45 34.4
E-99 0.35 14.2 0.28 6.6
E-153 0.43 17.4 2.49 59
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